Suchergebnisse - "Jindal, Tanya"

PubPharm (11)

1

Central Nervous System Disease Progression Among Patients With Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin : A Case Series

enthalten in: Clinical genitourinary cancer | 2024

von Shipp, C. | Jindal, T. | Chou, J. | +3

2

Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations

enthalten in: JCO precision oncology | 2024

von Park, J. | Chu, A. | Li, J. | +29

3

Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin

enthalten in: Clinical genitourinary cancer | 2023

von Jindal, T. | Zhang, L. | Deshmukh, P. | +24

4

Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC) : "Real World" Experience

enthalten in: Clinical genitourinary cancer | 2023

von Bakaloudi, D. | Talukder, R. | Lin, G. | +32

5

Somatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancer

enthalten in: Frontiers in oncology | 2023

von Jindal, T. | Zhu, X. | Bose, R. | +19

6

Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma

enthalten in: Clinical genitourinary cancer | 2023

von Makrakis, D. | Bakaloudi, D. | Talukder, R. | +21

7

Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma

enthalten in: Clinical genitourinary cancer | 2022

von Talukder, R. | Makrakis, D. | Lin, G. | +51

8

Repeat Treatment of Patients With Advanced Urothelial Carcinoma With Immune Checkpoint Inhibitors Following Prior Progression on a Checkpoint Inhibitor Regimen : A Case Series

enthalten in: Clinical genitourinary cancer | 2022

von Jindal, T. | Chou, J. | Friedlander, T. | +2

9

Efficacy of enfortumab vedotin in advanced urothelial cancer : Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study

enthalten in: Cancer | 2022

von Koshkin, V. | Henderson, N. | James, M. | +33

10

APOBEC Mutational Signature and Tumor Mutational Burden as Predictors of Clinical Outcomes and Treatment Response in Patients With Advanced Urothelial Cancer

enthalten in: Frontiers in oncology | 2022

von Natesan, D. | Zhang, L. | Martell, H. | +21